These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24848062)

  • 1. Progression of early retinal dysfunction in diabetes over time: results of a long-term prospective clinical study.
    Hellgren KJ; Agardh E; Bengtsson B
    Diabetes; 2014 Sep; 63(9):3104-11. PubMed ID: 24848062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non-high-risk proliferative diabetic retinopathy: a randomized clinical trial.
    Scott IU; Jackson GR; Quillen DA; Larsen M; Klein R; Liao J; Holfort S; Munch IC; Gardner TW
    JAMA Ophthalmol; 2014 May; 132(5):535-43. PubMed ID: 24604308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and structural change in diabetic eyes. Interim results from an ongoing longitudinal prospective study.
    Hellgren KJ; Bengtsson B; Agardh E
    Acta Ophthalmol; 2013 Nov; 91(7):672-7. PubMed ID: 23025256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
    Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E
    Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in mild to moderate nonproliferative diabetic retinopathy: a randomized proof-of-concept clinical trial.
    Scott IU; Jackson GR; Quillen DA; Klein R; Liao J; Gardner TW
    JAMA Ophthalmol; 2014 Sep; 132(9):1137-42. PubMed ID: 24969516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test-retest variability for standard automated perimetry and short-wavelength automated perimetry in diabetic patients.
    Bengtsson B; Hellgren KJ; Agardh E
    Acta Ophthalmol; 2008 Mar; 86(2):170-6. PubMed ID: 17935606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifocal Pupillography Identifies Changes in Visual Sensitivity According to Severity of Diabetic Retinopathy in Type 2 Diabetes.
    Sabeti F; Nolan CJ; James AC; Jenkins A; Maddess T
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4504-13. PubMed ID: 26200488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal micropseudocysts in diabetic retinopathy: prospective functional and anatomic evaluation.
    Forte R; Cennamo G; Finelli ML; Bonavolontà P; Greco GM; de Crecchio G
    Ophthalmic Res; 2012; 48(1):6-11. PubMed ID: 22205346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized retinal morphology and differential light sensitivity in diabetic retinopathy. Methodology and clinical results.
    Bek T
    Acta Ophthalmol Suppl (1985); 1992; (207):1-36. PubMed ID: 1486330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reduction of retinal light sensitivity in diabetic patients].
    Pahor D
    Klin Monbl Augenheilkd; 2003 Dec; 220(12):868-72. PubMed ID: 14704945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidimensional Functional and Structural Evaluation Reveals Neuroretinal Impairment in Early Diabetic Retinopathy.
    Joltikov KA; de Castro VM; Davila JR; Anand R; Khan SM; Farbman N; Jackson GR; Johnson CA; Gardner TW
    Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO277-BIO290. PubMed ID: 28973314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifocal electroretinogram and short-wavelength automated perimetry measures in diabetic eyes with little or no retinopathy.
    Han Y; Adams AJ; Bearse MA; Schneck ME
    Arch Ophthalmol; 2004 Dec; 122(12):1809-15. PubMed ID: 15596584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring retinal sensitivity with the microperimeter in patients with diabetes.
    Nittala MG; Gella L; Raman R; Sharma T
    Retina; 2012 Jul; 32(7):1302-9. PubMed ID: 22450513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated perimetric changes following panretinal photocoagulation in diabetic retinopathy.
    Khosla PK; Gupta V; Tewari HK; Kumar A
    Ophthalmic Surg; 1993 Apr; 24(4):256-61. PubMed ID: 8321507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].
    Wilczyński M; Dzivgielewski K
    Klin Oczna; 2006; 108(1-3):66-9. PubMed ID: 16883944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency-doubling technology perimetry for detection of the development of visual field defects in glaucoma suspect eyes: a prospective study.
    Liu S; Yu M; Weinreb RN; Lai G; Lam DS; Leung CK
    JAMA Ophthalmol; 2014 Jan; 132(1):77-83. PubMed ID: 24177945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy.
    Silva PS; Cavallerano JD; Sun JK; Noble J; Aiello LM; Aiello LP
    Am J Ophthalmol; 2012 Sep; 154(3):549-559.e2. PubMed ID: 22626617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual field progression with frequency-doubling matrix perimetry and standard automated perimetry in patients with glaucoma and in healthy controls.
    Redmond T; O'Leary N; Hutchison DM; Nicolela MT; Artes PH; Chauhan BC
    JAMA Ophthalmol; 2013 Dec; 131(12):1565-72. PubMed ID: 24177807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inner retinal visual dysfunction is a sensitive marker of non-proliferative diabetic retinopathy.
    Jackson GR; Scott IU; Quillen DA; Walter LE; Gardner TW
    Br J Ophthalmol; 2012 May; 96(5):699-703. PubMed ID: 22174096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.